USPTO 2015–2025 USPTO PatentsView US Corporation

CHS Healthcare Ventures, Inc.

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, CHS ranks #45,672 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#45,672
of 49,997 US assignees by volume
Top 33%
by Innovation Score (41.5/100)
10.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R45672 · US Corporation #45,672 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,672/49,997
  • PHOTO-FINISH Chow Sang Sang…
  • CPC-NARROW A61M · 7 areas
  • INNOV-PAR 41.5/100
  • CLAIMS-PAR 10.0 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Chow Sang Sang Jewellery Company Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around CHS

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows CHS's Innovation Score is 41.5/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where CHS's grants concentrate

CHS Healthcare Ventures, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 60% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2021. By volume, CHS sits between Chow Sang Sang Jewellery Company Limited and Ciel ET Terre International.

CHS's three-year grant acceleration

CHS Healthcare Ventures, Inc. shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CHS's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CHS holds 5 patents at rank #45,546, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CHS

By rank, the assignees closest to #45,546 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in CHS's primary technology class.

CHS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 33% higher than 67% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 202120232025 1
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
CHS Healthcare Ventures, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 20.0%
2023 3 60.0%
2025partial year 1 20.0%

Where it ranks

Overall rank by patents

#45,672

of 49,997 tracked assignees

Innovation Score

41.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CHS Healthcare Ventures, Inc.'s patent record in context - here's where to go next.

  • CHS Healthcare Ventures, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 60% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #45,672 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CHS Healthcare Ventures, Inc. against Chow Sang Sang Jewellery Company Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.